What does this research mean for the field?

Question

Accepted Answer

The cross-talk and interactions between GSK-3β, RKIP, and PTEN with multiple signaling pathways critically regulate tumor progression and resistance to therapy, highlighting their potential as therapeutic targets in cancer. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

The cross-talk between GSK-3β, RKIP, and PTEN as potential targets for therapeutic implications in cancer: a comprehensive insight

Discussion

Member takes

Overview

Key Points

Cite This Study